Article Information
- Received June 15, 1999
- Revision received October 21, 1999
- Accepted October 21, 1999
- First published January 15, 2000.
- Version of record published January 15, 2000.
Author Information
- Laura A. Mamounas1,
- C. Anthony Altar2,
- Mary E. Blue3,
- David R. Kaplan4,
- Lino Tessarollo5, and
- W. Ernest Lyons5
- 1Department of Pathology (Division of Neuropathology), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,
- 2Global Neuroscience Research, Otsuka America Pharmaceutical, Rockville, Maryland 20850,
- 3The Kennedy-Krieger Research Institute and Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,
- 4Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada, and
- 5Neural Development Group, Advanced Bioscience Laboratories Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702
Author contributions
Disclosures
- Received June 15, 1999.
- Revision received October 21, 1999.
- Accepted October 21, 1999.
This work was supported by National Institute of Mental Health Grant R29MH85433 (L.A.M.), a National Research Council National Institute on Aging/National Institutes of Health award (L.A.M.), and by the National Cancer Institute, Department of Health and Human Services, under contract with ABL (D.R.K, L.T., and W.E.L.). We thank Dr. Vassilis Koliatsos for helpful discussion and review of this manuscript, Dr. Randy Blakely for generously supplying the SERT antibody, Dr. Karen Axt for advice and assistance with SERT immunohistochemistry, and Dr. MaryAnn Wilson for advice and critical comments on axon density analysis.
Correspondence should be addressed to Dr. Laura A. Mamounas, Department of Pathology/Division of Neuropathology, The Johns Hopkins University School of Medicine, 558 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205. E-mail: Mamounas{at}welchlink.welch.jhu.edu.
Online Impact